Transaction · 0001669639-26-000004

Sanzone Virginia Ruth

Sanzone Virginia Ruth, VP, GC, reported an open-market or private sale at ICU MEDICAL INC DE involving 692.000000 shares for an estimated $118688.38. Reported holdings after the transaction were 14604.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SVP, GC
ICUIICU MEDICAL INC DE
Trade date
Sep 03, 2026
Filing date
Sep 03, 2026
View on SEC Insider profile
Estimated value-$118kShares × reported price
Shares traded692$171.52 per share
Holdings after14.6kDirect
% of reported position traded4.52%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 15,296 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

ICUI price since this filing

Daily closing prices, with the filing date and available return windows
ICUI · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago +2.1%
Returns since7d -5.4%30d -4.2%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001669639-26-000004
Common Stock
Transaction date
Sep 03, 2026
Filed Sep 03, 2026, 10:29 PM · 0d delay
Shares
692 sh
$171.52 per share
Estimated value
-$118k
Computed from shares × price
Holdings after
14,604 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 0

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

VP, General Counsel

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2026.

  2. F2

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.20 to $168.145, inclusive. The reporting person undertakes to p…

  3. F3

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $168.21 to $169.15, inclusive. The reporting person undertakes to pr…

  4. F4

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $169.5 to $169.665, inclusive. The reporting person undertakes to pr…

  5. F5

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.775 to $171.69, inclusive. The reporting person undertakes to p…

Original filing · 0001669639-26-000004
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

ICUI